Prostasomes are submicron secretory granules synthesized, stored and secreted by the epithelial cells of the human prostate gland. They are membrane-surrounded also in their extracellular appearance and the membrane architecture is composite. They are believed to be life-giving and act as protectors of the spermatozoa in the lower and upper female genital tract on their way to the ovum. Hence, the prostasomes are immunosuppressive and inhibitory of complement activation. Further, they promote sperm's forward motility and have antioxidant and antibacterial capacities. The prostasomes with their many composite abilities seem to turn against the host cell after the age of 50 y being conducive to the transition of the normal prostate epithelial cell into a neoplastic cell and therewith lay the foundations of the very high prevalence of prostate cancer of men of more than 50 y of age. Prostate Cancer and Prostatic Diseases (2004) 7, 21-31. doi:10.1038/sj.pcan.4500684
Prostate cancer
Prostate cancer is the most common cancer in men in Europe, North America, and some parts of Africa. Incidence of prostate cancer is increasing steadily in most countries. Incidence and death rates differ according to race and geographical location. 1 Different autopsy studies performed in Western and Oriental populations have shown that the prevalence of prostate cancer is significantly higher than its incidence. Comparative assessments of these studies have provided similar prevalence rates in different races and geographical areas. 2 The differences in the incidence of prostate cancer in different races and geographical areas and the different progression of this incidence in populations of a race living in a foreign geographical area, strengthen the hypothesis that genetic and lifestyle factors are responsible for the difference in post-induction progression of prostate cancer. 3, 4 The incidence rate of clinically apparent prostate cancer is eight-fold higher in the United States than in Japan, while the prevalence of latent prostate cancer, a presumed precursor of clinical prostate cancer, is similar in the two countries. 5 However, the initiating and promoting factors that determine the variability in the natural history of prostate cancer remain unknown. 6 There is a substantial discrepancy between the high incidence of prostate cancer and the extremely low incidence of primary cancer in the seminal vesicles, 7 although the two glands represent neighbouring anatomical locations, both of them being exocrine accessory genital glands and both being under similar hormonal control. Hence, there may be endogenous as well as exogenous factors promotive of prostate cancer development. We hypothesize that prostasomes with their exclusive origin in the prostate gland and with their extraordinary properties, may be important components among the endogenous factors responsible for the transition to cancer cell development and growth in the prostate. In this review, we discuss the role of prostasomes in a physiologic and pathophysiologic context.
Prostasomes and their organ origin
Prostasomes are submicron membranous vesicles with a mean diameter of 150 nm, range 40-500 nm. 8 They are found in storage vesicles and secreted by the human prostate gland and mixed in the semen at the moment of ejaculation. Prostasomes have been ascribed different biologic activities, but their physiologic function is still unclear. There is strong evidence that prostasomes are unique structures derived only from the prostate gland in man. 9, 10 This statement is based on the following lines of evidence.
An Mg
2+
-and/or Ca 2+ -ATPase activity was intimately associated with the membrane surrounding the prostasomes. 9, 11, 12 We compared the contents of this ATPase activity (a marker of prostasomes) and fructose (a seminal vesicle secretory product) in prostatic fluid, and seminal plasma from the same individuals. A high ATPase activity and a low fructose concentration was typical for prostatic fluid while a reverse situation was to hand in seminal fluid with a lowered concentration of the ATPase activity (due to 'dilution') and an increased concentration of fructose (due to contribution by the seminal vesicles). 9 Hence, the ATPase (and therewith the prostasome) contribution originated from the prostate gland and not from the other accessory glands. We also compared this ATPase activity in seminal plasma of 13 men before and after vasectomy and found no change in ATPase activity meaning that the contribution of spermatozoa with regard to ATPase activity and therewith prostasomes was nil. 13 A man displayed low seminal activities of ATPase in parallel with only scanty occurrence of prostasomes on repeated occasions but with an ordinary representation of fructose, 14 again emphasizing that the seminal vesicles, similar to the testes and epididymes, are not involved in the production of prostasomes.
Investigation of split ejaculate fractions revealed highest ATPase activities and highest frequency of prostasomes in the first two fractions, representing the prostatic contribution, and lowest ATPase activities and lowest frequency of prostasomes in the last two fractions that represent the seminal vesicles' contribution. 9 A strong correlation existed between ATPase activity and each of the bivalent cations Zn 2+ , Mg 2+ , and Ca 2+ in different split ejaculate fractions. 15 Since these bivalent cations are secreted only by the prostate gland, the correlation gives a firm basis for the idea, in analogy with the above-mentioned relationships, of a pure prostatic origin of prostasomes.
Another strong support for this idea is the observation of Wilson et al. 16 They determined the activity, which did not differ, of dipeptidyl peptidase IV (DPP IV) in seminal plasmas of vasectomized, azoospermic, oligozoospermic and normozoospermic men indicating no correlation with the concentration of spermatozoa originally present in the semen. Further, the DPP IV antigen (CD 26) and enzymic activity were present in prostatic secretion, but absent from that of the seminal vesicles. DPP IV (CD 26) is indeed a prostasome-membrane-associated dimer comprising two subunits of approximately 110 kDa. 16, 17 Hence, these observations on DPP IV antigen and enzymic activity are unambiguous evidences that prostasomes are unique structures originating from just one of the accessory genital glands, viz, the prostate gland.
It has been claimed that prostasomes have a composite origin in the urogenital tract. 18 The authors anchored their conclusions to their immunohistochemical findings using a polyvalent rabbit antiserum against a highly purified preparation of prostasomes. 18 However, a monoclonal antibody raised against purified prostasomes not only recognised prostasomes but also antigen epitopes from some other cells, for example, exocrine/ endocrine pancreatic cells, monocytes/macrophages and seminal vesicle epithelial cells. 10 Hence, present immunomarkers for prostasomes demonstrate varying degrees of crossreactivity to other cells, which means that such studies alone are not enough to constitute the basis for establishment of the organ origin of prostasomes in semen.
Secretion of prostasomes
The prostasomes are present as inclusions in storage vesicles of the prostate gland cells. 8, 19 The storage vesicles with the prostasome precursors reasonably originate from the Golgi membranes by a budding process, since there were no ultrastructural indications that the prostasomes were produced in the cytoplasm and then incorporated in the storage vesicles. 19 The prostasome membrane, regardless of prostasome isolation from seminal fluid, prostate tissue or prostate cancer bone metastasis, exhibited a very high cholesterol/ phospholipid ratio (approaching 2/1), 20 contrary to plasma membranes in general. The corresponding figure for human benign prostatic hyperplastic epithelial cells was 0.5/1.
21
The latter ratio agrees with that of human spermatozoa. 22, 23 Hence, there is little basis for the belief that membrane particles derived from the apical plasma membrane of prostatic secretory cells, fragments or portions from epididymal stereocilia, and membrane elements detached from spermatozoa were contributory to the formations of prostasomes as has been claimed. 18 Further, since the cholesterol/phospholipid ratio of the prostatic epithelial plasma membrane is below 1, a suggested apocrine secretion, that is, the release of prostasomes through apical protrusions or blebs, 18, 24, 25 can probably not be the releasing mechanism for prostasomes. Instead there are grounds for an ordinary exocytotic event involving fusion of the membranes surrounding the storage vesicle and the prostatic secretory cell being the releasing principle of prostasomes. 8 
Biochemical features of prostasomes
A recent proteomic analysis of human prostasomes applying capillary electrophoresis and mass spectrometry revealed that they contain at least 139 proteins subdivided in six categories. 26 They were enzymes Guanine nucleotide-binding proteins cycle between inactive GDP-bound and active GTP-bound states to regulate a diverse array of cellular processes like cell growth, apoptosis and differentiation. The occurrence of GDP in human prostasomes has been reported. 29 Molecular chaperones play a role in maintaining proper protein folding and in promoting protein deposition. Apparently, phospholipids, particularly phosphatidylethanolamine, may have a capacity to act as a nonprotein molecular chaperone in the folding and assembly of polytopic membrane proteins. 30 The phospholipid composition of prostasome membranes is notable. There is an unusually high content of sphingomyelin approaching 50%. 31, 32 Further, saturated and monounsaturated fatty acids were dominating both in the glycerophospholipids and in sphingomyelin. 31, 32 Cholesterol is known to be particularly abundant in membranes that contain saturated phospholipid acyl chains and have a high content of sphingomyelin. Accordingly, we found a remarkably high cholesterol/ phospholipid ratio approaching 2 31 regardless of prostasomal source being seminal plasma, prostate gland or prostate cancer bone metastasis. 20 The ordering of lipids in membrane systems is dependent on the cholesterol and sphingomyelin content and by the degree of saturation of the phospholipid acyl chains. This conclusion was confirmed by electron spin resonance (ESR) spectra performed on prostasome membranes showing very high order parameters. 31 As already mentioned, about one-third of the prostasomal proteins are enzymes among which several are oxidizing enzymes. Some of the other enzymes are linked to the prostasome membrane via a GPI (glycerylphosphatidylinositol) anchor. 33 Others are associated to the prostasome membrane in phospholipoprotein complexes like the ATPases with high ATP-splitting activity. 34, 35 Protein phosphorylation has been implicated in controlling metabolism, membrane transport, neurotransmission, genomic activation and cell proliferation. The phosphorylation reaction of a protein is carried out by protein kinases, which can be subdivided into two main groups depending on acceptor amino acid of the transferred phosphoryl group: alcohol groups on serine/threonine and phenolic groups on tyrosine in their respective protein residues. The serine/threonine protein kinases are either second-messenger (eg cyclic AMP) dependent or second-messenger independent. Protein kinases phosphorylating the tyrosine-containing protein residue include hormone receptor-associated kinases. Protein phosphorylation is controlled reversibly by protein phosphatases splitting off the phosphoryl group from the acceptor amino acid. Multiple forms of protein kinase activity are present in seminal fluid and not stimulated by cyclic AMP. [36] [37] [38] Histone and phosvitin are excellent exogenous acceptor proteins of the protein kinases, and prostate secretion may be the predominant contributor for at least the histone kinase. 37, 39 Approximately half the protein kinase activities in prostatic fluid are associated with prostasomes, 37, 40 and incubations of spermatozoa and prostasomes together resulted in a 10-fold increase in total protein phosphorylation compared to the level of phosphorylation achieved when either component was incubated alone. 37 No tyrosine kinase-catalysed phosphorylation in prostasomes has so far been reported. Gammaglutamyltransferase occurs in a very high concentration in human seminal plasma and most of it is bound to prostasomes. 26, 41, 42 Among the structural/transport proteins of prostasomes, six members of the annexin family were identified. 26 Annexins hold a central hydrophilic pore functioning as a Ca 2+ channel. Since prostasomes are rich in Ca 2+ and Zn
2+
, 15, 43 annexins may be involved in the recruitment of Ca 2+ to the prostasomes. A zinc-binding capacity of prostasomes was recently revealed 44 and this new property of prostasomes could affect spermatozoa in different ways by modulating the cation level in their microenvironment.
Functional characteristics of prostasomes
Prostasomes can adhere to and, at least to some extent, fuse with spermatozoa as shown in different ways. [45] [46] [47] Both spermatozoa and prostasomes display a netnegative surface charge when analysed in free-zone electrophoresis, and on comparison, prostasomes are slightly less negative than spermatozoa. 45 The interaction that can occur between prostasomes and spermatozoa is rather strong and most probably of a hydrophobic nature. 45 Immunostaining with anti-prostasome monoclonal antibody (mAb 78) demonstrated an adherence of prostasomes to spermatozoa. The staining occurred all over the spermatozoa especially on the mid-pieces and was weaker on the sperm heads. 48 The fusion was cationindependent, but pH-dependent and required one or more proteins on sperm and prostasome surfaces. 49 A fusion means a transfer of lipids 46 and proteins 50 from prostasomes to spermatozoa. Further, an increase of sperm Ca 2+ was proportional to the prostasomal fusion with spermatozoa. 51 Hence, prostasomes can, by physically close contact, influence and modify sperm characteristics in various ways.
Sperm motility
Sperm motility has been a critical factor in judging semen quality, and the type of this motility influences the fertilizing capability of spermatozoa. The motility pattern evoked by prostasomes [52] [53] [54] is bestowed on a successful oocyte fertilization, since motility is needed to penetrate the cervical mucus in the lower female reproductive tract, while, in the upper tract, vigorous beating of the sperm tail is necessary for the penetration of the zona pellucida. Also, the recovery of freeze-thawed and motile spermatozoa was increased, when the swimup medium was supplemented with prostasomes. 55 
Immunosuppressive activity
The prostasomes have been identified as inhibitors in lymphoproliferation assays. 56, 57 This activity accounts for a significant proportion of the immunosuppressive Janus-faced nature of prostasomes G Ronquist and BO Nilsson activity of human seminal plasma. 58 Since the prostasomes have the ability to adhere to spermatozoa, 45, 48 there is the probability that the immunosuppressive effect associated with the prostasomes can be carried up the female genital tract with the spermatozoa. 58 Pure preparations of prostasomes inhibit mitogen-induced lymphoproliferation in a dose-dependent fashion with a concentration of prostasomes equivalent to 40% of that seen in seminal plasma giving 69% suppression of thymidine incorporation. 58 A direct effect of prostasomes on macrophage function is also apparent. 56 Prostasomes bind rapidly to the leucocyte cell membrane followed by internalization of the adsorbed material. Interaction of prostasomes with neutrophils and monocytes inhibits their ability to phagocytose latex particles. 56 Similarly, endocytosis of prostasomes by the cells may suppress their ability to generate oxygen radicals. 56 Hence, phagocytosing cells will ingest prostasomes and consequently will become more or less inactivated. This would promote the survival of spermatozoa in the female genital tract.
Complement modulatory activity
Prostasomes contain in their membrane the (MAC) membrane attack complex inhibitory protein CD 59.
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There are reasons to believe that CD 59 is carried on the surface of the prostasomes in a GPI anchor and that spermatozoa may acquire CD 59 molecules as a result of interaction with the prostasomes. 59 Accordingly, prostasomes may represent a pool of CD 59 from which protein lost from spermatozoa, possibly as a result of normal membrane turnover or of low level complement attack, may be replenished, thus ensuring that the spermatozoa will advance in the female reproductive tract being guarded against the membrane attack complex. CD 55 (decay-accelerating factor) and CD 46 (membrane cofactor protein) are other prostasomal GPI-anchored inhibitors of complement activation.
Antioxidant capacity
Reactive oxygen species (ROS) are a major cause of idiopathic male infertility. An abnormally high production of ROS has been shown in 40% of semen samples from infertile individuals, while very few were found in samples from fertile donors. 60 Human spermatozoa are very sensitive to oxidative stress, resulting in peroxidative damage. This sensitivity is due to the high content of unsaturated fatty acids in their plasma membranes and their small cytoplasmic volume that limits their scavenging potential. 61 Controversy still exists regarding the origin of ROS in semen, but leucocytes infiltrating the semen, particularly the polymorphonuclear neutrophils seem to be the major source of ROS generation. 62 It has been shown that prostasomes can interact with neutrophils and reduce their capacity to produce superoxide anion after stimulation. 56 Hence, it was apparent that prostasomes could play a role as an antioxidant factor. This theme was further elaborated by Saez et al. 62 These authors noticed that prostasomes had the ability to reduce ROS production by sperm preparations containing polymorphonuclear neutrophils. Further studies revealed that prostasomes inhibited the NADPH oxidase activity of polymorphonuclear leucocytes and this inhibition was probably a result of lipid transfer from prostasomes to leucocytes. 63 
Antibacterial activity
Incubation with minute amounts of prostasomes results in a marked decrease or a total abrogation of outgrowth of Bacillus megaterium and some other bacterial strains. 64 The antibacterial activity is associated with bacterial membrane deformation and the creation of membrane cavities is a part of this process. Intact prostasomes were not an obligatory prerequisite for the antibacterial effect, since fractions obtained after detergent and ultrasonication treatment of prostasomes were also fully active. 64 
Prostasomes and prostate cancer growth Prostate cancer morphology
Both normal prostate epithelium and well-differentiated adenocarcinoma present polarized cylindrical cells with an ordered morphology. The prostasomes of both these cell-stages are present in storage vesicles located in the apical parts of the glandular cells 8, 19, 28 ( Figure 1 ). The poorly differentiated cells in prostate vertebral metastases, however, are cuboidal cells occurring in small cell conglomerates and are lacking an organized cytoplasmic structure (Figure 2 ). These cells carry many cellular processes, which make the metastases to an intricate system of cell bodies and interlacing cytoplasmic projections ( Figure 3) .
The storage vesicles of the well-differentiated cancer cells in the prostate begin developing at the Golgi apparatus. They contain a varying amount of secretory material and prostasome precursors (Figure 4) . The metastatic cells, in spite of their low degree of differentiation, also contain storage vesicles although in smaller numbers ( Figure 5 ). They are scattered in the cytoplasm of the cuboidal, unpolarized cells and are similar in structure to the storage vesicles of the welldifferentiated cells.
The prostasomes, noticed as small dark bodies, are secreted into the gland ducts both from normal prostate cells and from well-differentiated neoplastic cells (Figure 6a) . Also, the poorly differentiated metastatic cells do release prostasomes into the various spaces occurring among the cell groups of the metastases (Figure 6b ).
Prostasomal cancer-promoting properties
It is a long-known principle that tumour cells tend to exploit the host's physiologic systems in order to get support in terms of, for example, nutrition, growth or metastasis. It seems that several prostasomal abilities, which are developed to assist the fertilizing sperm cells, also can be promotive in the transition from a normal to a neoplastic cell and help the prostasome-producing, poorly differentiated neoplastic prostate cells to survive as metastases.
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Immunosuppressive and complement system inhibitory abilities
The object of the immune system is to distinguish self from non-self and thus to protect the individual. Tumour cells express an array of antigens recognized by cytotoxic T lymphocytes. 65, 66 The nature of the tumour antigens that mediate an immune response leading to tumour rejection is, however, unclear. 67 The epithelial cells of the prostate and seminal vesicles will be exposed more or less continuously to secretions of their own. In this matter, prostasomes, being constituents of prostate but not of seminal vesicle secretion, have been identified as inhibitors in lymphoproliferation assays. 56, 58 Due to this uneven occurrence of prostasomes between the prostate gland and seminal vesicles, it is tempting to suggest that the ability of prostasomes to counteract the immune defense may play a role in the very high prevalence of prostate cancer after 50 years of age (ie after the reproductive age of most men), contrasting to the extremely low prevalence of primary cancer in the seminal vesicles lacking prostasomes in their surroundings.
It has been proven clinically and experimentally that the complement system is involved in the immunosurveillance against tumours. 68 Complement activation on tumours may occur in response to the formation of immune complexes containing antitumour antibodies, spontaneous activation of the alternative pathway in response to altered cell surface expression 69 and by tissue destruction resulting from tissue ischaemia and necrosis. 70 Apparently, tumours use different mechanisms to evade the attack by the complement system. [71] [72] [73] Prostasomes contain CD 59 (protectin) on their surface 59 and on incubation with prostasomes, prostasomal CD 59, can be transferred to cells lacking CD 59 59, 74 rendering these acceptor cells valid defence against a complement attack. 74 Interestingly, prostate cancer metastatic cells were found to be surrounded by prostasomes (G Sahlén et al, unpublished 2003) giving these malignant cells an advantage of survival in an otherwise hostile environment.
Neuroendocrine properties
The diffuse neuroendocrine system consists of peptide hormone-producing cells in different locations through- Janus-faced nature of prostasomes G Ronquist and BO Nilsson out the body. 75 Neuroendocrine cells have been described in the prostate gland. 76 They are all capable of synthesizing and releasing amines, hormones (neuropeptides and regulatory peptides) and common protein markers, so called neuroendocrine markers, that can be detected immunohistochemically. The most used markers are chromogranins and synaptophysin, both of which being present in prostasomes. 77 Prostasomes, being the secretory product of prostate epithelial cells as shown immunohistochemically using a monoclonal antibody, 10 also contain vasoactive intestinal polypeptide (VIP) and neuropeptide Y. VIP is co-localized in nerves supplying prostate epithelium 78 and it can produce effects on cyclic AMP levels in prostate epithelial cells therewith playing a role in prostatic proliferation. 79 Hence, VIP is involved in the regulation of prostate growth and differentiation. 80, 81 Neuropeptide Y is found in high concentrations in the nerves supplying the prostate 82, 83 and may play a role in regulating the vascular supply to the prostate 78 (see below).
Invasive support
The invasive behaviour of many cancers including prostate cancer involves the increased expression of proteases that can decompose parts of the extracellular matrix, thus permitting passage of malignant cells through basement membranes and stromal barriers.
Among these enzymes, plasminogen activator and matrix metalloproteinases (see below) play important roles. 84, 85 Results obtained on the highly invasive 1-LN human prostate tumour cell line provided new evidence connecting DPP IV with the activation of plasminogen and the expression of matrix metalloproteinase-9 86 thus bringing about a degradation of extracellular matrix components and facilitating cancer invasion.
Dipeptidyl peptidase IV (EC 3.4.14.5, DPP IV) is a serine type peptidase, 87 that cleaves dipeptides from the amino end of peptide chains if the penultimate residue is proline or, although less efficiently, alanine 88 or hydroxyproline. 89 The cell-associated enzyme is an intrinsic membrane sialoglycoprotein, 90 which is anchored to the plasma membrane through a hydrophobic domain, most of the molecular mass being exposed to the outside of the cell. 91 As mentioned above, DPP IV is derived (among genital glands) nearly exclusively from the prostate gland and more precisely concentrated to an extremely high level in the membrane fraction of prostatic fluid, that is, the prostasomes. 16, 17, 92 DPP IV hydrolyses biologically active peptides, for example, substance P. 93 Substance P is among the various neuropeptides present Janus-faced nature of prostasomes G Ronquist and BO Nilsson in the prostate gland 94 (although there is so far no report on its occurrence in prostasomes) and it has been found occasionally elevated in plasma in connection with prostate cancer. 95 Hence, DPP IV seems to be involved in activation or deactivation of a broad range of biologically relevant peptides like also growth factors and cytokines. 96 Biochemical and histochemical analyses revealed that there was indeed an increased activity of DPP IV in prostatic cancer tissues. 97 This increased DPP IV activity may influence metabolism in favour of some biologically active peptides that change the tissue environment propitious to cancer growth. 97 Tissue factor is a cell membrane-associated glycoprotein which serves as a receptor and essential cofactor for factors VII and VIIa of the coagulation cascade. 98 Very high levels of tissue factor was found to originate on prostasomes in prostatic fluid with no occurrence at all in seminal vesicle secretions. 99 As a potent initiator of coagulation, tissue factor has critical functions in haemostasis and thrombogenesis. 100 Several studies have established a link between blood coagulation and cancer; more specifically between tissue factor and tumour metastasis. There is an increased incidence of thromboembolic disease in patients with cancers and, therefore, haemostatic abnormalities are common in these patients. Although metastasis is undoubtedly multifactorial, intravascular coagulation activation and peritumour fibrin deposition appear to be important causative agents. 101 Tissue factor is involved in angiogenesis 102 (see below), cell migration, 103 and tumour cell invasion. 104 More recently, it was demonstrated in human prostate cancer cells that tissue factor binds plasminogen with high affinity through an interaction between kringles 1-3 of plasminogen and the extracellular domain of tissue factor. 105 These actions may contribute to the roles that tissue factor and plasminogen play in the enhancement of tumour growth and metastasis. 85, 106 Angiogenetic capacity Tissue factor promotes angiogenesis through a mechanism involving the formation of a complex with activated factor VII (factor VIIa), which generates activated factor X (factor Xa), leading to the activation of thrombin that then stimulates the production of vascular endothelial growth factor. 107 As a matter of fact, immunohistochemical analysis of prostate cancer specimens localized tissue factor expression to the epithelial cells 108 that also express prostasomes. 109 Tissue factor expression was significantly correlated with tumour angiogenesis 108 emphasizing the role of prostasomal tissue factor for development and growth of prostate cancer. Angiotensin-1-converting enzyme (ACE, EC 3.4.15.1) is a zinc-metalloprotease that is detectable in all tissues and body fluids of mammals. 110 The activity of ACE is more than 50 times higher in seminal plasma than in serum and a majority of the seminal activity is membranebound to prostasomes. 111 ACE catalyses the conversion of a decapeptide, angiotensin I into the octapeptide, angiotensin II by splitting off the C-terminal dipeptide. Values for seminal plasma angiotensin II of normal men were manifold higher than those for blood with no correlation between the values from the two sources. 112 Angiotensin II stimulates neovascularization, 113, 114 which is a requirement for tumour growth. [113] [114] [115] Further, it can act as a growth factor with stimulation of cell replication in tissue culture 116, 117 and with an increase of the expression of genes that control cell growth. 118, 119 Hence, prostasomal membrane-bound ACE seems to operate autonomously 112 sustaining a high concentration of angiotensin II favouring cell proliferation.
Malignant conversion activity
The family of matrix metalloproteases (MMPs) consists of more than 20 related enzymes that degrade a variety of extracellular matrix components. 120 All MMPs share several highly conserved domains, including a prodomain that contains an activation locus and a catalytic domain that contains a zinc atom binding site. 121 Metalloproteases may play a role early in malignant conversion, perhaps by increasing growth through activation of growth factors and/or by facilitating angiogenesis, a process necessary for tumour to grow beyond 1-2 mm. 122 Aminopeptidase N (CD 13) is intimately linked to the prostasome membrane. 34, 42, 50 It is a zinc metalloprotease that has been suggested to play an important role in the pathophysiology of the development of tumours and it mediates the migration of human metastatic tumour cell lines through Matrigel. 123, 124 A subset of membrane-type MMPs seems to have special importance due to their membrane-surface localization. 120 Hence, malignant cells depend on these proteases to disrupt basement membranes, invade neighbouring tissues and metastasise to different organs and an increased expression of a 72 kDa MMP-2 was found to be associated with human prostate cancer progression. 125 It should, however, be pointed out that coordinated breakdown, synthesis and remodelling of the extracellular matrix are crucial events in normal physiological situations, such as embryonic development, reproduction, wound healing and angiogenesis. 126 No studies have so far been carried out to investigate whether MMPs are associated with prostasomes which occur not only in normal prostate epithelial cells 10 but also in malignant prostate epithelial cells. 109 
Concluding remarks
Prostasomes are unique secretory granules synthesized, stored and released by the human prostate epithelial cells. They possess a pluripotency by which they ensure the spermatozoa abilities to pass and survive in the lower and upper female genital tracts, to penetrate the zona pellucida and reach the egg for fertilization. These potencies of the prostasomes are, however, a doubleedged sword. Up to the age of 50 y, they apparently are important ingredients in the process leading to fertilization of the ovum and prostate cancer is diagnosed in very few men aged younger than 50 y (o0.1% of all patients). 127 After that age these potent abilities seem to turn against the host cell-either one by one or in concert-being conducive to the transition of the normal prostate epithelial cell into a neoplastic cell and therewith lay the foundations of the very high prevalence of prostate cancer of men of more than 50 y of age.
